Mitsubishi Heavy Industries
7011
FUJI Media Holdings
4676
SoftBank
9434
4
SoftBank Group
9984
5
Nippon Telegraph & Telephone
9432
JP Stock MarketDetailed Quotes
2370 Medinet
- 34
- 00.00%
20min DelayMarket Closed Jan 23 15:30 JST
8.99BMarket Cap-6.75P/E (Static)
35High34Low765.20KVolume34Open34Pre Close26.28MTurnover5752wk High0.32%Turnover Ratio264.52MShares3452wk Low-5.04EPS TTM8.25BFloat Cap13900Historical HighLossP/E (Static)242.58MShs Float33Historical Low-5.04EPS LYR2.94%Amplitude--Dividend TTM1.73P/B100Lot Size--Div YieldTTM
Medinet News
Medinet: Corporate Governance Report 2025/01/15
Medinet: Notice regarding partial revisions to the “29th Annual General Meeting of Shareholders Meeting Documents (matters not described in issuance documents based on laws and regulations and the Articles of Incorporation among electronic provision measures)”
Medinet: Notice regarding the recording of special profit (profit from sale of investment securities)
Medinet: Extraordinary Report
Medinet: Notice regarding changes in representative directors
Medinet: Confirmation
Medinet: Internal Control Report - 29th Period (2023/10/01 - 2024/09/30)
Medinet: Financial Report - 29th Term (2023/10/01 - 2024/09/30)
Medinet: Financial results briefing materials for the fiscal year ending 2024/9
Medinet: Convocation materials for the 29th Annual General Meeting of Shareholders for the fiscal year ending 2024/9 (matters not described in issuance documents)
Medinet: Notice of Convocation of the 29th Annual General Meeting of Shareholders for the fiscal year ending 2024/9
Medinet: Notice Concerning Election of Director Candidates and Audit & Supervisory Board Candidates
Medinet: Notice Concerning Decrease in Capital and Capital Reserve Amounts and Disposal of Surplus Funds
Medinet: Notice regarding the recording of non-operating income and extraordinary losses
Medinet: Summary of Financial Results 2024
Medinet: Summary of financial results for the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)
Medinet: Explanatory materials on business plans and growth potential
Medinet: (Changes in disclosure matters) Changes in the use of funds and planned expenditure periods relating to the issuance of stock acquisition rights through third-party allotment
Medinet: [Progress of disclosure matters] Decision to discontinue development of regenerative medicine products for the purpose of treating chronic heart failure
Medinet: (Changes in disclosure matters) Changes in the planned expenditure period relating to the issuance of stock acquisition rights through third-party allotment